Virus infections, blood clots and bleeding
Marco Goeijenbier
What do Ebola, Dengue Fever, Lassa Fever, or other hemorrhagic fevers, that often inspire Hollywood productions, have in common with respiratory viruses, such as influenza or Sars-Cov2?
Listen to Dr Marco Goeijenbier, intensivist at Spaarne Hospital in Haarlem and ESWI Board Member, expertly explain the complications due to changes in the coagulation system ranging from blood clotting to bleeding. Furthermore, in this captivating account, Marco describes why complications associated with virus infections seem to affect certain risk groups more than others. He clarifies what a super infection is and gives a reflection of how the Covid pandemic personally affected him working in an ICU.
Nationality: Dutch
Position: Intensivist, Spaarne Gasthuis, Amsterdam, The Netherlands
Research fields: Special interest in acute care and infectious diseases
ESWI member since 2016
Marco Goeijenbier graduated from medical school at the University of Amsterdam in 2010. During his internships he did research on rodent-borne hemorrhagic fever. Goeijenbier received his PhD in virology (“Haemostasis and Virus Infection”) from the Erasmus University Rotterdam in 2015. He was previously a specialist in acute internal medicine and started a fellowship in intensive care at Erasmus MC in Rotterdam. He currently holds the position of intensivist at Spaarne Hospital in Amsterdam.
Some of Goeijenbier’s most recent published articles include ; “Thrombocytopenia in Virus Infections. (J Clin Med, feb 2021)” “Determinants of Vaccination Uptake in Risk Populations (Vaccines, Aug 2020)”
And Benefits of flu vaccination for persons with diabetes mellitus (Vaccine, Sep 2017).
Dr. Goeijenbier is ESWI’s lead member and Chair in the Influenza Diabetes Community (IDC). The IDC connects leading diabetes, patient, scientific and professional organisations around the common aim of protecting persons living with diabetes from influenza and other viral respiratory diseases like COVID-19.